Duke Early Phase Research Unit (DEPRU) — Durham, North Carolina

Duke Early Phase Research Unit (DEPRU) is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Early Phase Research Unit (DEPRU) has participated in 1 clinical trials.

Therapeutic areas: Pulmonary Arterial Hypertension.

Sponsors: Roham T. Zamanian.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Early Phase Research Unit (DEPRU)?

Duke Early Phase Research Unit (DEPRU) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Early Phase Research Unit (DEPRU) conducted?

Duke Early Phase Research Unit (DEPRU) has 1 clinical trials on record. Their work covers Pulmonary Arterial Hypertension.

Is Duke Early Phase Research Unit (DEPRU) accredited by Crixeo Health?

Duke Early Phase Research Unit (DEPRU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Early Phase Research Unit (DEPRU)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.